These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33505917)

  • 21. Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile.
    Hou H; Zhu H; Zhao H; Yan W; Wang Y; Jiang M; Liu B; Liu D; Zhou N; Zhang C; Li P; Chang L; Guan Y; Wang Z; Zhang X; Li Z; Fang B; Zhang X
    Oncologist; 2018 Sep; 23(9):1008-1015. PubMed ID: 29700208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
    Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M
    J Thorac Oncol; 2016 Apr; 11(4):504-15. PubMed ID: 26774193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Relevance of PD-L1 Expression and CD8+ T Cells' Infiltration in Patients With Lung Invasive Mucinous Adenocarcinoma.
    Xu X; Li N; Wang D; Chen W; Fan Y
    Front Oncol; 2021; 11():683432. PubMed ID: 34249733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
    Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
    Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.
    Ma Z; Zhang Y; Deng C; Fu F; Deng L; Li Y; Chen H
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):e73-e85. PubMed ID: 32739163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma.
    Cui D; Xie S; Liu Q
    BMC Pulm Med; 2023 Jan; 23(1):9. PubMed ID: 36624430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
    Kadota K; Yeh YC; D'Angelo SP; Moreira AL; Kuk D; Sima CS; Riely GJ; Arcila ME; Kris MG; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Aug; 38(8):1118-27. PubMed ID: 25029118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma.
    Cai D; Li H; Wang R; Li Y; Pan Y; Hu H; Zhang Y; Gong R; Pan B; Sun Y; Chen H
    Onco Targets Ther; 2014; 7():2127-32. PubMed ID: 25429229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Clinicopathological Features and Prognosis between
    Li P; Gao Q; Jiang X; Zhan Z; Yan Q; Li Z; Huang C
    J Cancer; 2019; 10(1):61-71. PubMed ID: 30662526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Battle for Accuracy: Identifying the Most Effective Grading System for Lung Invasive Mucinous Adenocarcinoma.
    Jia J; Zhang G; Wei L; Qi L; Wang X; Li L; Zeng H; Wang J; Xue Q; Ying J; Xue L
    Ann Surg Oncol; 2024 Sep; 31(9):5717-5728. PubMed ID: 38847985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive mucinous adenocarcinoma of the lung.
    Xu L; Li C; Lu H
    Transl Cancer Res; 2019 Dec; 8(8):2924-2932. PubMed ID: 35117050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of mucin spread, tumor cell spread, and invasive size in invasive mucinous adenocarcinoma of the lung.
    Saito T; Tsuta K; Honda O; Ishida M; Yamaka R; Tanaka N; Ishida K; Utsumi T; Maru N; Matsui H; Taniguchi Y; Hino H; Kurata T; Murakawa T
    Lung Cancer; 2020 Aug; 146():50-57. PubMed ID: 32512273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma.
    Xu X; Shen W; Wang D; Li N; Huang Z; Sheng J; Rucker AJ; Mao W; Xu H; Cheng G
    Transl Lung Cancer Res; 2022 Mar; 11(3):420-431. PubMed ID: 35399567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study.
    Moon SW; Choi SY; Moon MH
    J Thorac Dis; 2018 Jun; 10(6):3595-3608. PubMed ID: 30069357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
    Chen LF; Chen XY; Yu XB
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
    Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
    Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma.
    Gow CH; Hsieh MS; Liu YN; Lee YH; Shih JY
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma.
    Liu DH; Zhao ZR; Lin YB; Zhou WJ; Hou JY; Ye ZH; Long H
    Ann Surg Oncol; 2019 Jun; 26(6):1934-1941. PubMed ID: 30820786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma.
    Duruisseaux M; McLeer-Florin A; Antoine M; Alavizadeh S; Poulot V; Lacave R; Rabbe N; Cadranel J; Wislez M
    Cancer Med; 2016 Dec; 5(12):3579-3585. PubMed ID: 27770508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.
    Yoon DW; Hwang S; Hong TH; Choi YL; Kim HK; Choi YS; Kim J; Shim YM; Cho JH
    Ann Surg Oncol; 2024 Jan; 31(1):201-212. PubMed ID: 37814186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.